However, for the SHP-77 cells without CD44 expression, despite the observed cholesterol reduction through MβCD and Simva treatments (Fig. 2), the membrane fluidity of this SCLC cell line remained unaffected (Fig. 7). This evidence concerns the gene CD44 and small cell lung carcinoma.